Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim; Heena Olalde; Kathleen Mays-Wilson; Melissa A. Yates; Karin Collard; Mohammad Hamed; Yuko Y. Palesch; Wayne M. Clark; Monica Dolan; Valerie Cwiklinski; Steven R. Messé; Chad Tremont; Anne Beckwith; Kimberly Kunze; Susanne Muehlschlegel; Kristine O’Phelan; David Huang; Kyra J. Becker; Rosita Thiessen; Vineeta Singh; Andrea Escobar; Guohua Xi; Sharon D. Yeatts; Michael L. James; Nicole R. Gonzales; Steven Verrault; Lesley Wasilewski; Patricia Tanzi; Robert Burfeind; Bradford Thompson; Claudia S. Moy; Kevin N. Sheth; Erlinda Yeh; Nicolaou Varelas; Enrique C. Leira; Supriya Save; Steven M. Greenberg; Michel Torbey; Casey Norton; Chitra Venkatasubramanian; Lewis B. Morgenstern; Kenneth Butcher; Lydia D. Foster; Leka Sivakumar; Charles Andrews; Cristina Falo; Michael D. Hill; Jan Claassen; Michael DeGeorgia; Iryna Nieto

doi:10.1016/s1474-4422(19)30069-9

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim(Beth Israel Deaconess Medical Center), Heena Olalde(University of Iowa Hospitals and Clinics), Kathleen Mays-Wilson, Melissa A. Yates, Karin Collard, Mohammad Hamed, Yuko Y. Palesch(Virginia Department of Health), Wayne M. Clark(Oregon Health & Science University), Monica Dolan, Valerie Cwiklinski, Steven R. Messé(Yale University), Chad Tremont, Anne Beckwith, Kimberly Kunze, Susanne Muehlschlegel, Kristine O’Phelan(University of Cambridge), David Huang(Oregon Health & Science University), Kyra J. Becker(Unknown), Rosita Thiessen, Vineeta Singh(San Francisco General Hospital), Andrea Escobar, Guohua Xi(University of Michigan), Sharon D. Yeatts(Medical University of South Carolina), Michael L. James(SUNY Upstate Medical University), Nicole R. Gonzales(Nicolet (Czechia)), Steven Verrault(Harvard University), Lesley Wasilewski, Patricia Tanzi, Robert Burfeind, Bradford Thompson(Rhode Island Hospital), Claudia S. Moy(National Institute of Neurological Disorders and Stroke), Kevin N. Sheth(Yale University), Erlinda Yeh, Nicolaou Varelas, Enrique C. Leira(University of Iowa), Supriya Save, Steven M. Greenberg(Harvard University), Michel Torbey(University of Alabama at Birmingham), Casey Norton(Beth Israel Deaconess Medical Center), Chitra Venkatasubramanian(Stanford Medicine), Lewis B. Morgenstern(University of Michigan), Kenneth Butcher(University of Alberta), Lydia D. Foster(Medical University of South Carolina), Leka Sivakumar, Charles Andrews(Boehringer Ingelheim (United States)), Cristina Falo, Michael D. Hill(University of Calgary), Jan Claassen(Columbia University), Michael DeGeorgia(Duke University), Iryna Nieto

The Lancet Neurology

March 18, 2019

10.1016/s1474-4422(19)30069-9

Cited by 249

Related Papers

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

|The Lancet|2016|7.6k

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

|Stroke|2019|7.2k

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

|New England Journal of Medicine|2015|6k

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

|Stroke|2018|5.5k

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

|The Lancet Neurology|2013|5.4k